SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-018641
Filing Date
2019-09-18
Accepted
2019-09-18 17:18:41
Documents
3
Period of Report
2019-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K innv20190917_8k.htm 8-K 55151
2 EXHIBIT 2.1 ex_158106.htm EX-2.1 769506
3 EXHIBIT 99.1 ex_158108.htm EX-99.1 30628
  Complete submission text file 0001437749-19-018641.txt   856676
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52991 | Film No.: 191100510
SIC: 2834 Pharmaceutical Preparations